196 related articles for article (PubMed ID: 35820682)
1. Comprehensive analysis of the expression and prognosis for RBR E3 ubiquitin ligases in lung adenocarcinoma.
Ding H; Wang Y; Cui Y; Chen Z; Li Y; Yang J; Yang Y; Chen T; Xia D; Li C; Xu C; Ding C; Zhao J
Thorac Cancer; 2022 Sep; 13(17):2459-2472. PubMed ID: 35820682
[TBL] [Abstract][Full Text] [Related]
2. RBR E3 ubiquitin ligases in tumorigenesis.
Wang P; Dai X; Jiang W; Li Y; Wei W
Semin Cancer Biol; 2020 Dec; 67(Pt 2):131-144. PubMed ID: 32442483
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of K63-ubiquitin chain formation by the Gordon-Holmes syndrome RBR E3 ubiquitin ligase RNF216.
Cotton TR; Cobbold SA; Bernardini JP; Richardson LW; Wang XS; Lechtenberg BC
Mol Cell; 2022 Feb; 82(3):598-615.e8. PubMed ID: 34998453
[TBL] [Abstract][Full Text] [Related]
4. Structure of a HOIP/E2~ubiquitin complex reveals RBR E3 ligase mechanism and regulation.
Lechtenberg BC; Rajput A; Sanishvili R; Dobaczewska MK; Ware CF; Mace PD; Riedl SJ
Nature; 2016 Jan; 529(7587):546-50. PubMed ID: 26789245
[TBL] [Abstract][Full Text] [Related]
5. Regulation of RNF144A E3 Ubiquitin Ligase Activity by Self-association through Its Transmembrane Domain.
Ho SR; Lee YJ; Lin WC
J Biol Chem; 2015 Sep; 290(38):23026-38. PubMed ID: 26216882
[TBL] [Abstract][Full Text] [Related]
6. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma.
Jing Y; Mao Z; Zhu J; Ma X; Liu H; Chen F
Int Immunopharmacol; 2023 Sep; 122():110605. PubMed ID: 37451021
[TBL] [Abstract][Full Text] [Related]
7. Coupled monoubiquitylation of the co-E3 ligase DCNL1 by Ariadne-RBR E3 ubiquitin ligases promotes cullin-RING ligase complex remodeling.
Kelsall IR; Kristariyanto YA; Knebel A; Wood NT; Kulathu Y; Alpi AF
J Biol Chem; 2019 Feb; 294(8):2651-2664. PubMed ID: 30587576
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
9. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
10. DCUN1D1 facilitates tumor metastasis by activating FAK signaling and up-regulates PD-L1 in non-small-cell lung cancer.
Li J; Yu T; Yan M; Zhang X; Liao L; Zhu M; Lin H; Pan H; Yao M
Exp Cell Res; 2019 Jan; 374(2):304-314. PubMed ID: 30528265
[TBL] [Abstract][Full Text] [Related]
11. Parkin-phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity.
Kumar A; Chaugule VK; Condos TEC; Barber KR; Johnson C; Toth R; Sundaramoorthy R; Knebel A; Shaw GS; Walden H
Nat Struct Mol Biol; 2017 May; 24(5):475-483. PubMed ID: 28414322
[TBL] [Abstract][Full Text] [Related]
12. RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.
Uchida C; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):157-74. PubMed ID: 26560116
[TBL] [Abstract][Full Text] [Related]
13. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis.
Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ
Front Immunol; 2021; 12():724741. PubMed ID: 34335635
[TBL] [Abstract][Full Text] [Related]
14. Expression of UBE2C in lung adenocarcinoma based on database analysis and its clinical significance.
Liu Y; Huang F; Chen H; Peng Q; Zhao C; Miao L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1044-1052. PubMed ID: 33051417
[TBL] [Abstract][Full Text] [Related]
15. RBR E3 ubiquitin ligases: new structures, new insights, new questions.
Spratt DE; Walden H; Shaw GS
Biochem J; 2014 Mar; 458(3):421-37. PubMed ID: 24576094
[TBL] [Abstract][Full Text] [Related]
16. Chain reactions: molecular mechanisms of RBR ubiquitin ligases.
Cotton TR; Lechtenberg BC
Biochem Soc Trans; 2020 Aug; 48(4):1737-1750. PubMed ID: 32677670
[TBL] [Abstract][Full Text] [Related]
17. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
18. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Chen A; Ding S; Shen X; Lin X
Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
[TBL] [Abstract][Full Text] [Related]
19. RNF213 inhibits migration in lung adenocarcinoma cell.
Liu X; Zeng H; Li Z; Wei C; Zhang Z; Liu X; Chen N
Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):286-292. PubMed ID: 38279417
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
